1 Start 2 Complete

Learner Demographics *

Physician

Nurse

Other

Overall Series Rating *

	Excellent	Satisfactory	Poor
Overall, how would you rate this series?	Overall, how would you rate this series? - Excellent	Overall, how would you rate this series? - Satisfactory	Overall, how would you rate this series? - Poor

Extent to which identified Series objectives were met: I am better able to ... *

	Outstanding	Good	Satisfactory	Fair	Poor
Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy.	Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy. - Outstanding	Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy. - Good	Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy. - Satisfactory	Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy. - Fair	Discuss molecular pathways of solid tumors (glioma, melanoma, colon, lung, thyroid, etc.) and hematologic malignancy. - Poor
Integrate molecular findings with morphology and clinical information.	Integrate molecular findings with morphology and clinical information. - Outstanding	Integrate molecular findings with morphology and clinical information. - Good	Integrate molecular findings with morphology and clinical information. - Satisfactory	Integrate molecular findings with morphology and clinical information. - Fair	Integrate molecular findings with morphology and clinical information. - Poor
Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected.	Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected. - Outstanding	Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected. - Good	Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected. - Satisfactory	Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected. - Fair	Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected. - Poor
Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient.	Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient. - Outstanding	Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient. - Good	Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient. - Satisfactory	Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient. - Fair	Consensus conference of the calling alterations with respect to a disease and the ethnicity of the patient. - Poor
Identify available clinical trials for the specific alterations.	Identify available clinical trials for the specific alterations. - Outstanding	Identify available clinical trials for the specific alterations. - Good	Identify available clinical trials for the specific alterations. - Satisfactory	Identify available clinical trials for the specific alterations. - Fair	Identify available clinical trials for the specific alterations. - Poor
Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).	Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Outstanding	Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Good	Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Satisfactory	Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Fair	Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Poor

Do you believe the subject matter presented/discussed was: *

	Yes	No
Objective	Objective - Yes	Objective - No
Fair & Balanced	Fair & Balanced - Yes	Fair & Balanced - No
Free of Commercial Bias	Free of Commercial Bias - Yes	Free of Commercial Bias - No

Have you made changes to your practice as a result of this series?

Yes

No

Please describe:

Do you have any recommendations for the moderator(s)/facilitator(s) of this series?

Yes

No

Please describe:

The Series included educational components that addressed cultural linguistic competency and implicit bias

Yes

No

N/A (If a research or non-direct patient care series)

Outside of this activity, what additional topics would you like addressed in other educational opportunities?

Leave this field blank